Study of MK-5684 Versus Alternative NHA in mCRPC (MK-5684-003)
Conditions: Prostate Cancer Metastatic Interventions: Drug: MK-5684; Drug: Abiraterone acetate; Drug: Enzalutamide; Drug: Hydrocortisone; Drug: Fludrocortisone acetate; Drug: Prednisone; Drug: Dexamethasone Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE ® + One Infusion of Sipuleucel-T
Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Sipuleucel-T Injection Sponsors: Dendreon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer
Conditions: Metastatic Hormone-Sensitive Prostate Cancer Interventions: Drug: Rezvilutamide; Drug: Rezvilutamide plus abiraterone; Drug: Continue previous treatment Sponsors: Jianbin Bi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Conditions: Androgen Deprivation Therapy; Locally Advanced Prostate Cancer Interventions: Drug: Relugolix and Enzalutamide Sponsors: University of Oklahoma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Kinesiophobia in Prostate Cancer
Conditions: Prostate Cancer; Kinesiophobia; Physical Inactivity Interventions: Other: survey evaluation Sponsors: Selcuk University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Conditions: Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Bone Scan; Radiation: Brachytherapy; Procedure: Computed Tomography; Procedure: Dual X-ray Absorptiometry; Radiation: External Beam Radiation Therapy; Procedure: Magnetic Resonance Imaging; Procedure: PSMA PET Scan; Other: Questionnaire Administration; Drug: Relugolix Sponsors: University of Kansas Medical Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Prostate Resection After Microwave Ablation (PRAMA)
Conditions: Prostate Carcinoma Interventions: Procedure: Biospecimen Collection; Device: Microwave Ablation; Device: Multiparametric Magnetic Resonance Imaging; Other: Questionnaire Administration; Procedure: Radical Prostatectomy Sponsors: University of Southern California; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
Conditions: Prostate Cancer Interventions: Diagnostic Test: Multiparametric magnetic resonance imaging (mpMRI) Sponsors: Chang Gung Memorial Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Enzalutamide 40mg; Drug: Amoxicillin 500mg; Drug: Metronidazole 400mg; Drug: Vancomycin 125mg; Drug: Ciprofloxacin 500g Sponsors: Institute of Cancer Research, United Kingdom; Prostate Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study
Conditions: Breast Cancer; Colorectal Cancer; Prostate Cancer Interventions: Behavioral: Geriatric Assessment and Promotora Coaching Sponsors: University of California, Davis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Conditions: Prostate Cancer; Newly-Diagnosed Prostate Cancer Interventions: Drug: [18F]PSMA-1007 Sponsors: ABX advanced biochemical compounds GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
AZD5305 vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Conditions: Metastatic Castration-Sensitive Prostate Cancer Interventions: Drug: AZD5305; Drug: Placebo; Drug: Abiraterone Acetate; Drug: Darolutamide; Drug: Enzalutamide Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy
Conditions: Aromatherapy; Prostate Cancer; Anxiety Interventions: Other: Aromatherapy Sponsors: Mersin Training and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)
Conditions: Prostate Cancer Interventions: Other: Animated video Sponsors: Direction Centrale du Service de Sant é des Armées Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Conditions: Prostate Cancer; Head and Neck Cancer; NSCLC; SCLC; Esophageal Cancer; Bladder Cancer; Rectum Cancer; Cervix Cancer; Other Carcinoma Interventions: Radiation: Online adaptive radiation therapy Sponsors: Charite University, Berlin, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
